Edesa Biotech Inc (EDSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,669 | -2,335 | -17,549 | -14,735 | -8,948 |
| Depreciation Amortization | 55 | 27 | 118 | 89 | 60 |
| Accounts receivable | 1,138 | 1,060 | 2,028 | 1,901 | 2,069 |
| Other Working Capital | 630 | 183 | 2,891 | 6,190 | 4,025 |
| Other Operating Activity | -517 | -727 | 233 | -96 | -829 |
| Operating Cash Flow | $-3,363 | $-1,791 | $-12,279 | $-6,651 | $-3,624 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -6 | -6 | -4 |
| Investing Cash Flow | $N/A | $N/A | $-6 | $-6 | $-4 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3,676 | 3,028 | 11,958 | 11,958 | 11,958 |
| Common Stock Repurchased | N/A | -116 | -328 | -328 | -328 |
| Financing Cash Flow | $3,676 | $2,912 | $11,630 | $11,630 | $11,630 |
| Exchange Rate Effect | 67 | 59 | -93 | -4 | 47 |
| Beginning Cash Position | 7,091 | 7,091 | 7,839 | 7,839 | 7,839 |
| End Cash Position | 7,471 | 8,270 | 7,091 | 12,809 | 15,887 |
| Net Cash Flow | $380 | $1,179 | $-748 | $4,970 | $8,048 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,363 | -1,791 | -12,279 | -6,651 | -3,624 |
| Capital Expenditure | N/A | N/A | -6 | -6 | -4 |
| Free Cash Flow | -3,363 | -1,791 | -12,285 | -6,657 | -3,629 |